505986 SR95531 (Gabazine) - CAS 104104-50-9 - Calbiochem

505986
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₁₅H₁₇N₃O₃•HBr 104104-50-9

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.05986.0001
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA selective, competitive antagonist of GABAA receptor (IC50 = 440 nM) that does not affect pentobarbitone or etomidate- induced currents even at high concentrations (~100 µM). Also shown to block glycine receptors, but with low affinity (Kb = 190 µM).
      Catalogue Number505986
      Brand Family Calbiochem®
      SynonymsGABAA Receptor Antagonist, SR-95531, Gabazine, SR95531, SR 95531
      References
      ReferencesMuroi, Y., et al. 2009. Biophys. J. 96, 499.
      Beato, M., et al. 2007. J. Physiol. 580, 171.
      Uchida, I., et al. 1996. Eur. J. Pharmacol. 307, 89.
      Product Information
      CAS number104104-50-9
      FormWhite solid
      Hill FormulaC₁₅H₁₇N₃O₃•HBr
      Chemical formulaC₁₅H₁₇N₃O₃•HBr
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetGABAA
      Primary Target IC<sub>50</sub>440 nM
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      SR95531 (Gabazine) - CAS 104104-50-9 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Muroi, Y., et al. 2009. Biophys. J. 96, 499.
      Beato, M., et al. 2007. J. Physiol. 580, 171.
      Uchida, I., et al. 1996. Eur. J. Pharmacol. 307, 89.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-September-2013 JSW
      SynonymsGABAA Receptor Antagonist, SR-95531, Gabazine, SR95531, SR 95531
      DescriptionA selective, competitive antagonist of GABAA receptor (IC50 = 440 nM) that does not affect pentobarbitone or etomidate- induced currents even at high concentrations (~100 mM). Also shown to block glycine receptors, but with low affinity (Kb = 190 mM).
      FormWhite solid
      CAS number104104-50-9
      Chemical formulaC₁₅H₁₇N₃O₃•HBr
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (25 mM)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesMuroi, Y., et al. 2009. Biophys. J. 96, 499.
      Beato, M., et al. 2007. J. Physiol. 580, 171.
      Uchida, I., et al. 1996. Eur. J. Pharmacol. 307, 89.